Trends in Biotechnology: Implications for the Pharmaceutical Industry

Abstract

Biotechnology is changing the pharmaceutical industry and, in the process, is reshaping the future of healthcare. The structure of the pharmaceutical industry is moving from vertical to horizontal, the value chain is changing from sequential to integrated. The system will be largely customer-driven. There will be shifts from blockbuster drugs to personalised medicine, from treatments to prevention, from hospitalisation to home care.

Keywords

biotechnology business history pharmacogenomics and personalised medicine

Get full access to this article

View all access options for this article.

References

Enriquez

Goldberg

(2000) ‘Transforming life, transforming business: the life science revolution’, Harvard Business Review, Harvard Business School Publishing, Cambridge, MA, March 1.

Hood

Leroy

(2001) ‘Genomics in the information age’, BIO 2001, San Diego, June 25.

Oliver

(2000) The Coming Biotech Age: The Business of Bio-Materials. McGraw Hill, New York.